Requiring that certain health insurance plans impose a no-cost sharing requirement for a diagnostic or supplemental breast cancer examination for breast cancer imposed on an insured.
Died in Committee
Summary
The bill would prohibit any deductible, coinsurance, or copayment for medically necessary diagnostic or supplemental breast cancer examinations for people covered by health insurance plans that include breast cancer screening. It applies to policies issued, renewed or amended on or before Jan. 1, 2026, with limited exceptions for high‑deductible plans under federal HSA rules. The measure failed in committee and did not become law.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 2296 changes status, plus AI-powered summaries and stage predictions.
Sign up free